Innovation Exchange Amsterdam explore all our activities
Menu Close
Associated websites:

IXA

The knowledge transfer office of UvA, HvA, VU and Amsterdam UMC

Visit Website

Amsterdam Science & Innovation Award

The award for the most innovative, knowledge based idea of Amsterdam

Visit Website

Amsterdam Venture Studios

Amsterdam hub for innovative knowledge based startups

Visit Website

Demonstrator Lab

Pre-incubator, learning-by-doing, entrepreneurship laboratory

Visit Website

Entrepreneurship Cases Amsterdam

Bringing entrepreneurship education to a higher level

Visit Website

Research Facilities Amsterdam

Access to high-end research instruments, facilities and expertise

Visit Website
Home / About IXA

About IXA

Innovation Exchange Amsterdam (IXA) is the expert interface between Amsterdam-based universities and parties interested in their research findings and knowledge, such as companies, educational institutions, investors, health care providers, entrepreneurs, government bodies and societal organisations. Being an interface, IXA deploys its expertise in both directions: assisting researchers in generating societal and economic impact from their work and assisting external parties in navigating the academic landscape to find a solution or spot an opportunity.

IXA is a collaboration between the Knowledge Transfer Offices of:

  • Amsterdam University Medical Centre
  • Amsterdam University of Applied Sciences/ Hogeschool van Amsterdam
  • University of Amsterdam
  • Vrije Universiteit Amsterdam

A story of VU startup Fitsurance

Fitsurance and how they ‘pivot’ during COVID-19, as a VU ‘personal health’ startup All was lost (well, almost) After a great pilot-project in Zeeland, where we measured runners on the beach, to see what a 3-day running event did with runners’ health,  we stepped up our efforts to prepare for 2020, in order to make […]

News

Amsterdam UMC and AlphaBiomics initiate collaboration to validate biologics treatment response predictor RxSelexTM in patients suffering from inflammatory bowel disease

This collaboration is part of 2-year UK government-funded project to bring RxSelexTM closer to patients Amsterdam UMC and AlphaBiomics Ltd., a United Kingdom (UK)-based precision medicine company, have initiated a collaboration to personalize care in patients suffering from inflammatory bowel disease (IBD). IBD patient response to biologics therapy is highly variable, with some patients receiving long-term benefits, […]

News

Haermonics ontvangt investering voor betere zorg na openhartchirurgie

Haermonics, een spin-off van Amsterdam UMC, heeft de effectiviteit en veiligheid bewezen van het spoelen van het hartzakje na een openhartoperatie. Een experimentele opstelling zorgde voor significant minder bloedingsgerelateerde complicaties. BOM Brabant Ventures en GAP Technologies investeren in het bedrijf voor de verdere ontwikkeling van de apparatuur en de disposables. Haermonics blijft samenwerken met Amsterdam […]

News